123 related articles for article (PubMed ID: 15893672)
1. Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition.
Barton WA; Tzvetkova D; Nikolov DB
Structure; 2005 May; 13(5):825-32. PubMed ID: 15893672
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.
Barton WA; Tzvetkova-Robev D; Miranda EP; Kolev MV; Rajashankar KR; Himanen JP; Nikolov DB
Nat Struct Mol Biol; 2006 Jun; 13(6):524-32. PubMed ID: 16732286
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering.
Davis S; Papadopoulos N; Aldrich TH; Maisonpierre PC; Huang T; Kovac L; Xu A; Leidich R; Radziejewska E; Rafique A; Goldberg J; Jain V; Bailey K; Karow M; Fandl J; Samuelsson SJ; Ioffe E; Rudge JS; Daly TJ; Radziejewski C; Yancopoulos GD
Nat Struct Biol; 2003 Jan; 10(1):38-44. PubMed ID: 12469114
[TBL] [Abstract][Full Text] [Related]
4. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization.
Bogdanovic E; Nguyen VP; Dumont DJ
J Cell Sci; 2006 Sep; 119(Pt 17):3551-60. PubMed ID: 16895971
[TBL] [Abstract][Full Text] [Related]
5. A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2.
Wu X; Zhao R; Li Z; Yao M; Wang H; Han J; Qu S; Chen X; Qian L; Sun Y; Xu Y; Gu J
Biochem Biophys Res Commun; 2004 Mar; 315(4):1004-10. PubMed ID: 14985112
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
[TBL] [Abstract][Full Text] [Related]
7. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands.
Seegar TC; Eller B; Tzvetkova-Robev D; Kolev MV; Henderson SC; Nikolov DB; Barton WA
Mol Cell; 2010 Mar; 37(5):643-55. PubMed ID: 20227369
[TBL] [Abstract][Full Text] [Related]
8. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
[TBL] [Abstract][Full Text] [Related]
9. Functional inhibition of secreted angiopoietin: a novel role for angiopoietin 1 in coronary vessel patterning.
Ward NL; Van Slyke P; Dumont DJ
Biochem Biophys Res Commun; 2004 Oct; 323(3):937-46. PubMed ID: 15381091
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells.
Yacyshyn OK; Lai PF; Forse K; Teichert-Kuliszewska K; Jurasz P; Stewart DJ
Angiogenesis; 2009; 12(1):25-33. PubMed ID: 19116766
[TBL] [Abstract][Full Text] [Related]
11. Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis.
Milner CS; Hansen TM; Singh H; Brindle NP
Microvasc Res; 2009 Mar; 77(2):187-91. PubMed ID: 18848573
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietins and angiopoietin-like proteins in angiogenesis.
Morisada T; Kubota Y; Urano T; Suda T; Oike Y
Endothelium; 2006; 13(2):71-9. PubMed ID: 16728326
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2804-7. PubMed ID: 18929866
[TBL] [Abstract][Full Text] [Related]
14. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas.
Lee OH; Xu J; Fueyo J; Alonso MM; Liu D; Martin V; Jiang H; Piao Y; Liu TJ; Gomez-Manzano C
Oncogene; 2008 Feb; 27(9):1310-4. PubMed ID: 17704802
[TBL] [Abstract][Full Text] [Related]
16. The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site.
Chatwell L; Holla A; Kaufer BB; Skerra A
Mol Immunol; 2008 Apr; 45(7):1981-94. PubMed ID: 18061677
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-mediated endothelial P-selectin translocation: cell signaling mechanisms.
Maliba R; Brkovic A; Neagoe PE; Villeneuve LR; Sirois MG
J Leukoc Biol; 2008 Feb; 83(2):352-60. PubMed ID: 17984290
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking.
Pfaff D; Fiedler U; Augustin HG
J Leukoc Biol; 2006 Oct; 80(4):719-26. PubMed ID: 16864601
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for angiopoietin-1-mediated signaling initiation.
Yu X; Seegar TC; Dalton AC; Tzvetkova-Robev D; Goldgur Y; Rajashankar KR; Nikolov DB; Barton WA
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7205-10. PubMed ID: 23592718
[TBL] [Abstract][Full Text] [Related]
20. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling.
Eklund L; Olsen BR
Exp Cell Res; 2006 Mar; 312(5):630-41. PubMed ID: 16225862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
